P08514 (ITA2B_HUMAN) Homo sapiens (Human)
Integrin alpha-IIb UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
70 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Cryo-EM Structures of Full-length Integrin alphaIIbbeta3 in Native Lipids |
Heteromer P05106; | 2×NAG; 2×NAG; 1×NAG; 1×NAG; 7×CA; 5×NAG; 2×CLR; 1×MG; | ||||
Assess | ||||||
Full length Integrin AlphaIIbBeta3 in inactive state |
Heteromer P05106; | 1×NAG; 1×NAG; 2×NAG; 7×CA; 3×NAG; 1×MG; | ||||
Assess | ||||||
Structure of complete ectodomain of integrin aIIBb3 |
Heteromer P05106; | 2×NAG; 1×NAG; 1×NAG; 1×NAG; 7×CA; 2×NAG; 1×IMD; 1×MG; | ||||
Assess | ||||||
The Extracellular Domain of Integrin AlphaIIbBeta3 in Intermediate State |
Heteromer P05106; | 2×NAG; 1×NAG; 6×CA; 2×NAG; 1×MG; | ||||
Assess | ||||||
Three-dimensional reconstruction of intact human integrin alphaIIbbeta3 in a phospholipid bilayer n… |
Heteromer P05106; | 2×NAG; 1×NAG; 1×NAG; 1×NAG; 2×NAG; | ||||
Assess | ||||||
The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does… |
Heteromer P05106; | 1×NAG; 1×NAG; 6×CA; 2×GOL; 3×SO4; 1×MG; 1×NAG; | ||||
Assess | ||||||
Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P05106; | 1×NAG; 1×NAG; 4×GOL; 3×SO4; 4×CA; 1×CL; 3×MN; 1×NAG; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with EF5154 |
Heteromer P05106; | 1×NAG; 1×NAG; 6×CA; 3×SO4; 1×MG; 1×NAG; 1×IR7; | ||||
Assess | ||||||
Structure of headpiece of integrin aIIBb3 in open conformation |
Heteromer P05106; | 1×NAG; 6×CA; 3×NAG; 2×MG; 1×CAC; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with cRGDfV |
Heteromer P05106; | 1×NAG; 1×NAG; 4×CA; 8×GOL; 6×SO4; 3×MN; 1×NAG; | ||||
Assess | ||||||
Integrin alphaIIbbeta3 in complex with AGDV peptide |
Heteromer P05106; | 1×NAG; 1×NAG; 4×CA; 5×SO4; 1×GOL; 3×MN; 1×NAG; | ||||
Assess | ||||||
Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P05106; | 1×NAG; 1×NAG; 2×SO4; 4×CA; 3×MN; 1×NAG; | ||||
Assess | ||||||
Integrin alphaIIbbeta3 in complex with AGDV peptide |
Heteromer P05106; | 1×NAG; 1×NAG; 2×SO4; 4×CA; 3×MN; 1×NAG; | ||||
Assess | ||||||
Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P05106; | 1×NAG; 1×NAG; 4×SO4; 4×CA; 3×MN; 1×NAG; | ||||
Assess | ||||||
Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P05106; | 1×NAG; 1×NAG; 3×SO4; 4×CA; 3×MN; 1×NAG; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with BMS4-3 |
Heteromer P05106; | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×MWO; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with GR144053 |
Heteromer P05106; | 1×NAG; 1×NAG; 7×SO4; 4×CA; 3×MN; 1×NAG; 1×MJX; | ||||
Assess | ||||||
A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ f… |
Heteromer P05106; | 1×NAG; 1×NAG; 4×SO4; 1×GOL; 6×CA; 1×CL; 1×MG; 1×NAG; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with BMS compound 4 |
Heteromer P05106; | 1×NAG; 1×NAG; 6×SO4; 6×CA; 1×MG; 1×NAG; 1×I7R; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with BMS4-1 |
Heteromer P05106; | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×M6K; | ||||
Assess | ||||||
The Closed Headpiece of Integrin alphaIIB beta3 and its Complex with an alpahIIB beta3 -Specific An… |
Heteromer P05106; | 1×NAG; 1×NAG; 6×CA; 7×GOL; 4×SO4; 1×MG; 1×NAG; | ||||
Assess | ||||||
Integrin alphaIIbbeta3 in complex with sibrafiban |
Heteromer P05106; | 1×NAG; 1×NAG; 4×SO4; 1×GOL; 6×CA; 1×MG; 1×NAG; 1×XQS; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with gantofiban |
Heteromer P05106; | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×MV8; | ||||
Assess | ||||||
Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P05106; | 1×NAG; 1×NAG; 5×GOL; 2×SO4; 4×CA; 3×MN; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with BMS4.2 |
Heteromer P05106; | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×NJF; | ||||
Assess | ||||||
The Closed Headpiece of Integrin IIb 3 and its Complex with an IIb 3 -Specific Antagonist That Does… |
Heteromer P05106; | 1×NAG; 1×NAG; 6×CA; 1×NIF; 7×GOL; 9×SO4; 1×MG; 1×NAG; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with lamifiban |
Heteromer P05106; | 1×NAG; 1×NAG; 4×SO4; 1×GOL; 6×CA; 1×CL; 1×MG; 1×NAG; 1×NB9; | ||||
Assess | ||||||
Integrin alphaIIB beta3 headpiece and RGD peptide complex |
Heteromer P05106; | 1×NAG; 1×NAG; 14×SO4; 6×CA; 1×MG; 1×NAG; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with UR2922 in Mn2+ |
Heteromer P05106; | 1×NAG; 1×NAG; 6×SO4; 4×CA; 1×GOL; 3×MN; 1×NAG; 1×I1F; | ||||
Assess | ||||||
A Novel High Affinity Integrin alphaIIbbeta3 Receptor Antagonist That Unexpectedly Displaces Mg2+ f… |
Heteromer P05106; | 1×NAG; 1×NAG; 6×CA; 1×RC2; 4×SO4; 1×NAG; 1×CL; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with lamifiban (Mn) |
Heteromer P05106; | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×NB9; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with sibrafiban (Mn) |
Heteromer P05106; | 1×NAG; 1×NAG; 3×SO4; 4×CA; 2×GOL; 3×MN; 1×NAG; 1×XQS; | ||||
Assess | ||||||
Integrin alphaIIbbeta3 in complex with AGDV-NH2 peptide |
Heteromer P05106; | 1×NAG; 1×NAG; 4×CA; 4×SO4; 1×GOL; 3×MN; 1×NAG; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with BMS compound 4 in Mn2+ |
Heteromer P05106; | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×I7R; | ||||
Assess | ||||||
Integrin alphaIIbbeta3 in complex with Ro-435054 |
Heteromer P05106; | 1×NAG; 1×NAG; 3×SO4; 1×GOL; 5×CA; 1×MG; 1×NAG; 1×5YB; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with fradafiban |
Heteromer P05106; | 1×NAG; 1×NAG; 4×SO4; 1×GOL; 6×CA; 1×MG; 1×NAG; 1×MWX; 1×CL; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with Eptifibatide |
Heteromer P05106; | 1×NAG; 1×NAG; 6×CA; 2×SO4; 1×MG; 1×NAG; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with roxifiban (Mn/Ca) |
Heteromer P05106; | 1×NAG; 1×NAG; 5×SO4; 4×CA; 3×MN; 1×NAG; 1×N9U; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with lotrafiban |
Heteromer P05106; | 1×NAG; 1×NAG; 5×SO4; 5×CA; 1×MG; 1×NAG; 1×MWI; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with a gantofiban analog |
Heteromer P05106; | 1×NAG; 1×NAG; 3×SO4; 4×CA; 2×MN; 1×NAG; 1×NJ9; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with fradafiban (Mn/Ca) |
Heteromer P05106; | 1×NAG; 1×NAG; 5×SO4; 1×GOL; 4×CA; 3×MN; 1×NAG; 1×MWX; 1×CL; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with UR2922 |
Heteromer P05106; | 1×NAG; 1×NAG; 6×CA; 5×SO4; 1×MG; 1×NAG; 1×I1F; | ||||
Assess | ||||||
Integrin alaphIIBbeta3 complex with Tirofiban |
Heteromer P05106; | 1×NAG; 1×NAG; 6×CA; 2×NAG; 5×SO4; 1×MG; 1×AGG; | ||||
Assess | ||||||
Integrin AlphaIIbBeta3 Headpiece Bound to a chimeric Fibrinogen Gamma chain peptide, LGGAKQRGDV |
Heteromer P02679; P05106; | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | ||||
Assess | ||||||
Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide, HHLGGAKQAGDV |
Heteromer P02679; P05106; | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | ||||
Assess | ||||||
Integrin AlphaIIbBeta3 Headpiece Bound to a Chimeric Fibrinogen Gamma chain peptide, HHLGGAKQRGDV |
Heteromer P02679; P05106; | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | ||||
Assess | ||||||
Re-refinement of Integrin AlphaIIbBeta3 Headpiece |
Heteromer P05106; | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×CAC; 1×MG; | ||||
Assess | ||||||
Re-refinement of Integrin AlphaIIbBeta3 Headpiece |
Heteromer P05106; | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×CAC; 1×MG; | ||||
Assess | ||||||
Integrin AlphaIIbBeta3 Headpiece Bound to Fibrinogen Gamma chain peptide,LGGAKQAGDV |
Heteromer P02679; P05106; | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | ||||
Assess | ||||||
Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist Eptifibatide |
Heteromer P05106; | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×MG; | ||||
Assess | ||||||
Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the plate… |
Heteromer P05106; | 1×NAG; 6×CA; 2×NAG; 1×CAC; 1×MG; | ||||
Assess | ||||||
Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist Tirofiban |
Heteromer P05106; | 1×NAG; 1×NAG; 2×GOL; 6×CA; 3×NAG; 1×AGG; 1×MG; | ||||
Assess | ||||||
Re-refinement of Integrin AlphaIIbBeta3 Headpiece Bound to Antagonist L-739758 |
Heteromer P05106; | 1×NAG; 1×NAG; 2×MG; 2×GOL; 6×CA; 3×NAG; 1×180; | ||||
Assess | ||||||
Integrin AlphaIIbBeta3-PT25-2 Complex |
Heteromer P05106; | 1×NAG; 1×NAG; 1×NAG; 6×CA; 1×NAG; 1×MG; | ||||
Assess | ||||||
Structure of the integrin AlphaIIbBeta3-Abciximab complex |
Heteromer P05106; | 6×CA; 1×MG; | ||||
Assess | ||||||
Cryo-EM Structures of Full-length Integrin alphaIIbbeta3 in Native Lipids complexed with Eptifibati… |
Heteromer P05106; | 2×NAG; 1×NAG; 2×NAG; 6×CA; 1×MG; | ||||
Assess | ||||||
Platelet integrin ALFAIIB-BETA3 transmembrane-cytoplasmic heterocomplex |
Heteromer P05106; | |||||
Assess | ||||||
Structure of the integrin aIIb(W968V)b3 transmembrane complex |
Heteromer P05106; | |||||
Assess | ||||||
Integrin alphaIIb-beta3 transmembrane complex |
Heteromer P05106; | |||||
Assess | ||||||
Structure of the Integrin alphaIIb-beta3(A711P) Transmembrane Complex |
Heteromer P05106; | |||||
Assess | ||||||
Filamin complex-2 |
Heteromer P21333; | |||||
Assess | ||||||
The structure of Filamin repeat 21 bound to integrin |
Heteromer P05106; P21333; | |||||
Assess | ||||||
Platelet integrin alfaIIb-beta3 cytoplasmic domain |
Heteromer P05106; | |||||
Assess | ||||||
Solution Structure of the Membrane Proximal Regions of alpha-IIb and beta-3 Integrins |
Heteromer P05106; | |||||
Assess | ||||||
Solution Structure of the Membrane Proximal Regions of alpha-IIb and beta-3 Integrins |
Heteromer P05106; | |||||
Assess | ||||||
Bicelle-embedded integrin alpha(IIB) transmembrane segment | monomer | |||||
Assess | ||||||
SOLUTION STRUCTURE OF THE CONSTITUTIVELY ACTIVE MUTANT OF THE INTEGRIN ALPHA IIB CYTOPLASMIC DOMAIN. | monomer | |||||
Assess | ||||||
NMR structure of the cytoplasmic domain of integrin AIIb in DPC micelles | monomer | |||||
Assess | ||||||
SOLUTION STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE INTEGRIN ALPHA-IIB SUBUNIT | monomer | |||||
Assess | ||||||
filamin complex-1 | monomer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
8t2v.1.A | monomer | 0.80 | 5×CA; | 100.00 | ||
Assess |
6 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 8t2v.1.A | monomer | 0.80 | 5×CA; 1×NAG; | 99.69 | |
Assess | ||||||
Isoform 2 | 4cak.1.A | monomer | 0.66 | 97.87 | ||
Assess | ||||||
Isoform 3 | 3fcs.1.A | monomer | 0.82 | 5×CA; 1×IMD; | 99.66 | |
Assess | ||||||
Isoform 3 | 6avr.1.A | monomer | 0.67 | 40.71 | ||
Assess | ||||||
Isoform 3 | 4cak.1.A | monomer | 0.65 | 99.66 | ||
Assess | ||||||
Isoform 3 | 6avu.1.A | monomer | 0.64 | 42.56 | ||
Assess |